Trial Information
The Correlation Between the Moment of Bevacizumab theRapy initiatiOn and the Efficacy in patieNt With Metastatic Breast Cancer Treated With First Line Regimens Based On AvaStin
Inclusion Criteria:
- Adult patients, >/=18 years of age
- Previously untreated metastatic breast cancer
- Scheduled to start 1st line chemotherapeutic treatment
- ECOG performance status 0-1
Exclusion Criteria:
- Any conditions included in contraindication list for Avastin
- Prior chemotherapy for metastatic breast cancer
- Adjuvant/neoadjuvant chemotherapy or radio-chemotherapy of non-metastatic malignancy
completed <6 months prior to treatment start
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Correlation between the time from start of chemotherapy to the start of Avastin treatment with progression-free survival
Outcome Time Frame:
60 months
Safety Issue:
No
Principal Investigator
Clinical Trials
Investigator Role:
Study Director
Investigator Affiliation:
Hoffmann-La Roche
Authority:
Romania: Ministry of Health
Study ID:
ML25191
NCT ID:
NCT01277133
Start Date:
June 2010
Completion Date:
September 2014
Related Keywords:
- Breast Cancer
- Breast Neoplasms